Literature DB >> 30953186

Prevalence of oral HPV infection in cervical HPV positive women and their sexual partners.

T K Eggersmann1, K Sharaf2, P Baumeister2, C Thaler1, C J Dannecker1, U Jeschke1, S Mahner1, K Weyerstahl3, T Weyerstahl4, F Bergauer4, J K S Gallwas5,6.   

Abstract

PURPOSE: Human papillomavirus (HPV) infection represents the primary cause of anogenital premalignant and malignant disease. Regarding the high prevalence of cervical HPV infection and the increasing incidence of HPV associated oropharyngeal cancer in recent years, a significant viral transmission from the cervical to the oral site, possibly depending on the sexual behavior must be considered. The present study aims to determine the prevalence of oral HPV infection in cervical HPV positive and negative women and their sexual partners.
METHODS: Cervical HPV positive and negative women and their sexual partners took part in the study. Cervical smears, oral smears and mouthwashes were taken from women attending gynecological outpatient clinics in two different institutions. Further, oral smears as well as mouthwashes of their sexual partners were obtained whenever possible. HPV genotyping was performed using the Cobas® polymerase chain reaction and nucleic acid hybridization assay for the detection of 14 high-risk HPV types. In addition, all participants were invited to complete a personal questionnaire.
RESULTS: 144 HPV positive and 77 HPV negative women and altogether 157 sexual partners took part in the study. Age, sexual behaviour, medication, smoking and alcohol consumption were distributed equally in both groups. Cervical HPV positive women had a significantly higher number of sexual partners. One woman with a HPV positive cervical smear and one partner of a woman with a HPV positive cervical smear showed an oral HPV infection. No oral HPV infections were detected in the HPV negative control group. The overall incidence of oral HPV infection was 0.5%, the incidence of oral HPV infection in women with a positive cervical smear was 0.7%.
CONCLUSION: The data demonstrate that the overall risk of an oral HPV infection is low. HPV transmission to the oropharynx by autoinoculation or oral-genital contact constitute a rare and unlikely event.

Entities:  

Keywords:  Cervical carcinoma; HPV; OSCC; Oropharyngeal carcinoma; Sexually transmitted disease

Mesh:

Year:  2019        PMID: 30953186     DOI: 10.1007/s00404-019-05135-7

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

1.  Association of Thiamine Intake with Human Papillomavirus (HPV) Infection in American Women: A Secondary Data Analysis Based on the National Health and Nutrition Examination Survey from 2003 to 2016.

Authors:  Yue-Xi Zhou; Fang-Fang Zhu; Chi Chen; Ying-Xuan Zhang; Xiao-Li Lv; Jing-Wei Li; Song-Ping Luo; Jie Gao
Journal:  Med Sci Monit       Date:  2020-11-13

2.  Human papillomavirus and Chlamydia trachomatis in oral and genital mucosa of women with normal and abnormal cervical cytology.

Authors:  J P Mosmann; S Zayas; A X Kiguen; R F Venezuela; O Rosato; C G Cuffini
Journal:  BMC Infect Dis       Date:  2021-05-05       Impact factor: 3.090

3.  Low Rates of Dual-Site and Concordant Oral-Cervical Human Papillomavirus Infections and Cancers: A Systematic Review.

Authors:  Kelsey H Jordan; Chloe M Beverly Hery; Xiaochen Zhang; Electra D Paskett
Journal:  Front Oncol       Date:  2022-03-29       Impact factor: 6.244

4.  Sequential acquisition of human papillomavirus infection between genital and oral anatomic sites in males.

Authors:  Brittney L Dickey; Wenyi Fan; Deepti Bettampadi; Richard R Reich; Bradley Sirak; Martha Abrahamsen; Maria Luiza Baggio; Lenice Galan; Roberto Carvalho Silva; Jorge Salmerón; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  Int J Cancer       Date:  2021-07-14       Impact factor: 7.316

5.  Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine.

Authors:  Nicolas F Schlecht; Martin Masika; Angela Diaz; Anne Nucci-Sack; Anthony Salandy; Sarah Pickering; Howard D Strickler; Viswanathan Shankar; Robert D Burk
Journal:  JAMA Netw Open       Date:  2019-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.